Literature DB >> 25170961

Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus.

A Pivert1, A Servant-Delmas, F Lunel-Fabiani, H Le Guillou-Guillemette, S Laperche, A Ducancelle.   

Abstract

Hepatitis B virus (HBV) basal core promoter (BCP) and precore (PC) mutations, HBV viral load and HBV surface antigen (HBsAg) quantitation were screened to assess correlations between these HBV markers in asymptomatic chronic hepatitis B carriers in France. From January 2006 to July 2007, 200 sera were collected from patients who were discovered to be HBsAg-positive when they volunteered to give blood. Direct sequencing of precore/core gene was used to detect A1762T/G1764A mutations in the BCP and G1896A in the PC region. HBV viral load and HBsAg were quantified with two commercials assays. The prevalence of the BCP and PC mixed/mutants were 37% and 60% respectively (P = 0.0001). HBV DNA level and HBsAg titer were significantly lower in subjects harboring the mixed/mutant PC virus compared to those infected by the wild phenotype. No significant difference was observed in HBV viral loads of blood donors infected by wild or mixed/mutant BCP viruses. Mutant or mixed PC virus was associated with male gender, HBeAb-positive status and HBV/D and HBV/E genotypes. BCP mutations were associated with age, and both HBV/A-HBV/E genotypes.The genetic properties of HBV in this cohort showed that most of the blood donors had a negative HBeAg serological status and harbored the PC mutant phenotype in combination with low levels of both HBV DNA and HBsAg. As the study was conducted in healthy subjects who could be considered as asmptomatic carriers, these results suggest a possible protective effect of the G1896A mutation against severe liver lesions.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  G1896A mutation; HBsAg titre; basal core promoter mutation; blood donor; hepatitis B

Mesh:

Substances:

Year:  2014        PMID: 25170961     DOI: 10.1002/jmv.24064

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  A Highly Prevalent Polymorphism in the Core Region Impairs Quantification of Hepatitis B Virus (HBV) by the cobas TaqMan HBV Assay.

Authors:  Laure Boizeau; Annabelle Servant-Delmas; Alexandra Ducancelle; Stéphane Chevaliez; Vincent Thibault; Syria Laperche; Pierre Cappy
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

Review 2.  Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Mol Biol Rep       Date:  2020-12-09       Impact factor: 2.316

3.  Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Authors:  Eleanor A Powell; Ceejay L Boyce; Maemu P Gededzha; Selokela G Selabe; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Gen Virol       Date:  2016-03-31       Impact factor: 3.891

4.  Clinical implication and viral mutation in basal core promoter/pre-core of hepatitis B virus C/D recombinant.

Authors:  Hua Li; Qilu She; Yu Liu; Yuehe Ding; Shenghua Shi; Jijie Li; Hongkai Wu; Zhanhui Wang
Journal:  Hepatol Int       Date:  2018-07-24       Impact factor: 6.047

5.  Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity.

Authors:  Md Golzar Hossain; Keiji Ueda
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

6.  Prevalence and Characteristics of Precore Mutation in Iran and Its Correlation with Genotypes of Hepatitis B.

Authors:  Ali Kargar Kheirabad; Gholamreza Farshidfar; Sadegh Nasrollaheian; Hamed Gouklani
Journal:  Electron Physician       Date:  2017-04-25

7.  Prevalence and Characteristics of Basal Core Promoter Mutations in Iran and its Correlation with Acute and Chronic Hepatitis B Infection.

Authors:  Sadegh Nasrollaheian; Gholamreza Farshidfar; Ali Kargar Kheirabad; Hamed Gouklani
Journal:  Electron Physician       Date:  2016-12-25

8.  Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.

Authors:  Pierre Gantner; Laurent Cotte; Clotilde Allavena; Firouzé Bani-Sadr; Thomas Huleux; Claudine Duvivier; Marc-Antoine Valantin; Christine Jacomet; Véronique Joly; Antoine Chéret; Pascal Pugliese; Pierre Delobel; André Cabié; David Rey
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

9.  Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients.

Authors:  Linlin Yan; Henghui Zhang; Hui Ma; Di Liu; Wei Li; Yulin Kang; Ruifeng Yang; Jianghua Wang; Gaixia He; Xingwang Xie; Hao Wang; Lai Wei; Zuhong Lu; Qixiang Shao; Hongsong Chen
Journal:  Sci Rep       Date:  2015-12-09       Impact factor: 4.379

10.  Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes.

Authors:  Fahime Bahri; Ali Kargar Kheirabad; Iman Ghasemzadeh; Saeed Shoja; Hamed Gouklani
Journal:  Hepat Mon       Date:  2016-01-23       Impact factor: 0.660

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.